BRIEF published on 07/30/2026 at 19:36, 3 months 11 days ago SPINEWAY: 2026 Half-Year Results Growth Half-year Results International Development Spineway Simple Obligations
BRIEF published on 07/30/2026 at 19:36, 3 months 11 days ago Spineway Reports H1 2026 Financial Results Financial Results Revenue Growth Medical Education Bond Issuance Spineway
PRESS RELEASE published on 07/30/2026 at 19:31, 3 months 11 days ago Spineway : H1 2026 results Spineway reports H1 2026 results reflecting continued growth and stable performance. Issuance of straight bonds to finance future growth. Strong embedded growth drivers in international expansion of product range Growth Strategy Medical Education Straight Bonds Spineway H1 2026 Results
BRIEF published on 04/07/2026 at 08:05, 7 months 3 days ago Spineway's General Meeting Approves Resolutions Growth Strategy Shareholders General Meeting Resolutions Spineway
PRESS RELEASE published on 04/07/2026 at 08:00, 7 months 3 days ago SPINEWAY : Minutes of the General Meeting of April 2, 2026 Spineway shareholders approved resolutions at the General Meeting, except for one. CEO thanks shareholders for support. Next event: April 30, 2026 - first-quarter revenue announcement Shareholders Revenue General Meeting CEO Spineway
BRIEF published on 02/17/2026 at 19:05, 8 months 21 days ago Spineway Reports 4% Revenue Growth for 2025 Financial Results Revenue Growth 2025 Spineway Spinal Implants
PRESS RELEASE published on 02/17/2026 at 19:00, 8 months 21 days ago Spineway : 2025 annual results Spineway reports 4% revenue growth and improved financial results in 2025, strengthening growth potential. Board approves financial statements, emphasizing net income improvement Financial Results Revenue Growth Net Income Growth Potential Spineway
BRIEF published on 01/13/2026 at 18:35, 9 months 28 days ago Spineway: 2025 Review and Q4 Growth Revenue Strategic Diversification Spineway Q4 Growth Spinal Implants
BRIEF published on 10/22/2025 at 08:35, 1 year ago Evolution Surgical to distribute Spineway disc prostheses in Australia Australia Distribution Spineway Surgical Evolution Disc Prostheses
BRIEF published on 10/14/2025 at 18:52, 1 year ago Spineway Reports Positive Third Quarter Revenue Growth Revenue Growth Spineway Export Sales Third Quarter 2025 Premium Ranges
Published on 11/10/2026 at 14:45, 5 hours 17 minutes ago An Investigational Drug to Tackle Measles Outbreaks
Published on 11/10/2026 at 14:31, 5 hours 31 minutes ago First Breach Plans to Integrate Onboard AI Computing into CQS and LRS Drone Platforms
Published on 11/10/2026 at 14:30, 5 hours 32 minutes ago Stabilis Solutions Announces Three-Year Take-Or-Pay LNG Supply Agreement with Existing Aerospace Customer
Published on 11/10/2026 at 14:30, 5 hours 32 minutes ago ACCESS Newswire Reports Third Quarter 2026 Results
Published on 11/10/2026 at 14:00, 6 hours 2 minutes ago Horizon Aircraft Completes Preliminary Design Review of Cavorite X7 Hybrid eVTOL
Published on 11/10/2026 at 18:54, 1 hour 7 minutes ago REPLOID Group AG pursues entry in the US market and secures exclusivity to conduct due diligence for the potential acquisition of Chapul, LLC.
Published on 11/10/2026 at 18:45, 1 hour 17 minutes ago Special Optics Introduces Purpose-Built Microscope Objectives for Quantum Applications
Published on 11/10/2026 at 18:30, 1 hour 32 minutes ago Shelly Group Accelerates Revenue Growth in the Third Quarter and Confirms Full-Year 2026 Guidance
Published on 11/10/2026 at 18:20, 1 hour 41 minutes ago Edison issues report on Custodian Property Income REIT (LSE: CREI)
Published on 11/10/2026 at 17:31, 2 hours 30 minutes ago CNP Assurances SA announces the success of the issuance of a €500 million Tier 2 subordinated bond.
Published on 11/10/2026 at 14:00, 6 hours 2 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from November 2 to November 6, 2026
Published on 11/10/2026 at 11:02, 8 hours 59 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 13 hours 2 minutes ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/09/2026 at 18:30, 1 day 1 hour ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
